← back to search

Liying Wang

Changsha Medical University · CN
Area of research
Pulmonary and Respiratory Medicine · Hepatology
Research interest
Research interests include Chronic Obstructive Pulmonary Disease (COPD) Research, Hepatocellular Carcinoma Treatment and Prognosis, Advanced Radiotherapy Techniques, and Respiratory Support and Mechanisms.
h-index
39
citations
5,283
works
230
NIH funding
primary concept
email

Recent publications

Self‐Directed High‐Intensity Interval Versus Moderate Continuous Training on Cardiometabolic Health in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Randomized Controlled Trial
Scandinavian Journal of Medicine & Science in Sports 2026cited by 1position: contributordoi
Automated Whole-Liver Fat Quantification with Magnetic Resonance Imaging-Derived Proton Density Fat Fraction Map: A Prospective Study in Taiwan
Gut and Liver 2025cited by 2position: contributordoi
Effects of Inspiratory Muscle Training in Patients With Chronic Obstructive Pulmonary Disease Exacerbations: A Randomized Controlled Trial.
2025cited by 1position: contributordoi
Cysteine-Based Redox-Responsive Nanoparticles for Fibroblast-Targeted Drug Delivery in the Treatment of Myocardial Infarction
ACS Nano 2023cited by 62position: middledoi
A Ferroptosis-Inducing and Leukemic Cell-Targeting Drug Nanocarrier Formed by Redox-Responsive Cysteine Polymer for Acute Myeloid Leukemia Therapy
ACS Nano 2023cited by 48position: middledoi
Natural ursolic acid based self-therapeutic polymer as nanocarrier to deliver natural resveratrol for natural therapy of acute kidney injury
Journal of Nanobiotechnology 2023cited by 21position: middledoi
Advances in Encapsulation and Delivery Strategies for Islet Transplantation
Advanced Healthcare Materials 2021cited by 70position: middledoi
Inspiratory muscle activation during inspiratory muscle training in patients with COPD.
2021cited by 10position: contributordoi
Effect of Synchronous Versus Sequential Regimens on the Pharmacokinetics and Biodistribution of Regorafenib with Irradiation.
2021cited by 10position: contributordoi
Treatment of Psoriasis Vulgaris with Medicated Thread Moxibustion of Zhuang Medicine: A Multicenter Randomized, Parallel Controlled Trial
Chinese Journal of Integrative Medicine 2021cited by 8position: middledoi
Impact of Local Liver Irradiation Concurrent Versus Sequential with Lenvatinib on Pharmacokinetics and Biodistribution.
2021cited by 4position: contributordoi
Spatial Heterojunction in Nanostructured TiO<sub>2</sub> and Its Cascade Effect for Efficient Photocatalysis
Nano Letters 2020cited by 100position: middledoi
Helical tomotherapy with a complete-directional-complete block technique effectively reduces cardiac and lung dose for left-sided breast cancer.
2020cited by 16position: contributordoi
Robust combination of liver stereotactic body radiotherapy modulates pharmacokinetics of sorafenib toward preferable parameters.
2020cited by 12position: contributordoi
Local Irradiation Modulates the Pharmacokinetics of Metabolites in 5-Fluorouracil-Radiotherapy-Pharmacokinetics Phenomenon.
2020cited by 9position: contributordoi
Prophylactic NS-21 maintains the skin moisture but does not reduce the severity of radiation dermatitis in patients with head and neck cancer: a randomized control trial.
2019cited by 9position: contributordoi
Depth-Camera-Based System for Estimating Energy Expenditure of Physical Activities in Gyms.
2019cited by 8position: contributordoi
Simultaneous integrated boost with helical arc radiotherapy of total skin (HEARTS) to treat cutaneous manifestations of advanced, therapy-refractory cutaneous lymphoma and leukemia - dosimetry comparison of different regimens and clinical application.
2019cited by 5position: contributordoi
Trajectories of functional exercise capacity in patients undergoing pulmonary rehabilitation.
2019cited by 5position: contributordoi
Neonatal respiratory status predicts longitudinal respiratory health outcomes in preterm infants.
2019cited by 5position: contributordoi
siRNA-mediated inactivation of HER3 improves the antitumour activity and sensitivity of gefitinib in gastric cancer cells
Oncotarget 2017cited by 10position: middledoi
MST4 promotes hepatocellular carcinoma epithelial-mesenchymal transition and metastasis via activation of the p-ERK pathway
International Journal of Oncology 2014cited by 53position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 6 papers (2019–2026)Xinru You · Brigham and Women's Hospital4 papers (2021–2023)Jun Wu · Kunming Medical University3 papers (2023–2023)Ping-Lun Hsieh · National Taiwan University2 papers (2025–2026)Chun-Jen Liu · Zhejiang University2 papers (2025–2026)Chih‐Horng Wu · Elsevier, Inc.2 papers (2025–2026) · 2 papers (2019–2021)Wei-Kai Wu · National Taiwan University2 papers (2025–2026)Yabin Meng · Sun Yat-sen University2 papers (2023–2023)Zhenzhen Li · Guangzhou University of Chinese Medicine1 papers (2017–2017)Yu Han · Zhejiang A & F University1 papers (2017–2017)Yijie Guo · Sun Yat-sen University1 papers (2023–2023)Yanfeng Liu · Fudan University1 papers (2014–2014)Tong Tong · Fujian Normal University1 papers (2023–2023)Tong Tong · Suzhou University of Science and Technology1 papers (2023–2023)Yushan Lei · Sun Yat-sen University1 papers (2023–2023)Ming-Yuan Song · Taiwan Semiconductor Manufacturing Company (Taiwan)1 papers (2023–2023)Jing Tang · Lomonosov Moscow State University1 papers (2021–2021)Zhongyan Chen · Guangdong University of Education1 papers (2023–2023)Peng Huang · Nanchang University1 papers (2017–2017)